News
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neuroreparative ...
1d
Medpage Today on MSNBTK Inhibitors for Multiple SclerosisMultiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
Limb tingling or numbness should not be ignored. These sensations may point to nerve issues. Spinal problems, carpal tunnel, ...
A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat ...
The development of drugs to treat major diseases of the central nervous system relies in part on ... the spinal cord and peripheral NS. Almost everyone is confronted one day with a NS syndrome ...
AlzeCure receives positive FDA response regarding Phase II/III studies with ACD440 in a rare disease
STOCKHOLM, SE / ACCESS Newswire / June 12, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN ...
4d
Tribune Online on MSNMost neurological disorders underdiagnosed in Nigeria, stronger healthcare needed for patients —Moses Ataben, neuroscientist, US-based scholarMoses Ataben is pursuing a neuroscience PhD at the University of Missouri–Columbia in the United States. Backed by ...
Beyond dizziness, you want to look out for the sudden onset of “the worst headache of your life and any loss of limb function ...
The bedroom has become an unlikely laboratory for sleep researchers, who are discovering that the right musical choices can ...
A punch biopsy reliably detected a biomarker of neurodegenerative disease in a small cohort of older adults diagnosed with ...
Flies that expressed an Alzheimer’s disease-related protein in their neurons showed signs of accelerated aging.
The unusual collaboration between Chinese vaccine researchers and neuroscientists raises questions about how early China knew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results